These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Buprenorphine withdrawal syndrome in newborns: a report of 13 cases. Kayemba-Kay's S, Laclyde JP. Addiction; 2003 Nov; 98(11):1599-604. PubMed ID: 14616186 [Abstract] [Full Text] [Related]
26. Brain magnetic resonance imaging of infants exposed prenatally to buprenorphine. Kahila H, Kivitie-Kallio S, Halmesmäki E, Valanne L, Autti T. Acta Radiol; 2007 Mar; 48(2):228-31. PubMed ID: 17354146 [Abstract] [Full Text] [Related]
27. [Is buprenorphine a potential alternative to methadone for treating pregnant drug users? Inventory of clinical data in the literature]. Loustauneau A, Auriacombe M, Daulouede JP, Tignol J. Ann Med Interne (Paris); 2002 Nov; 153(7 Suppl):2S31-6. PubMed ID: 12518080 [Abstract] [Full Text] [Related]
28. Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy. Liu AJ, Jones MP, Murray H, Cook CM, Nanan R. Aust N Z J Obstet Gynaecol; 2010 Jun; 50(3):253-8. PubMed ID: 20618243 [Abstract] [Full Text] [Related]
29. [Drug withdrawal in newborns - clinical data of 49 infants with intrauterine drug exposure: what should be done?]. Bläser A, Pulzer F, Knüpfer M, Robel-Tillig E, Vogtmann C, Nickel P, Kiess W. Klin Padiatr; 2008 Jun; 220(5):308-15. PubMed ID: 18260044 [Abstract] [Full Text] [Related]
30. Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates. Winklbaur B, Kopf N, Ebner N, Jung E, Thau K, Fischer G. Addiction; 2008 Sep; 103(9):1429-40. PubMed ID: 18783498 [Abstract] [Full Text] [Related]
31. Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication. Kaltenbach K, Holbrook AM, Coyle MG, Heil SH, Salisbury AL, Stine SM, Martin PR, Jones HE. Addiction; 2012 Nov; 107 Suppl 1(0 1):45-52. PubMed ID: 23106926 [Abstract] [Full Text] [Related]
32. Does Maternal Buprenorphine Dose Affect Severity or Incidence of Neonatal Abstinence Syndrome? Wong J, Saver B, Scanlan JM, Gianutsos LP, Bhakta Y, Walsh J, Plawman A, Sapienza D, Rudolf V. J Addict Med; 2018 Nov; 12(6):435-441. PubMed ID: 29905586 [Abstract] [Full Text] [Related]
33. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome. Winhusen T, Wilder C, Wexelblatt SL, Theobald J, Hall ES, Lewis D, Van Hook J, Marcotte M. Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042 [Abstract] [Full Text] [Related]
35. Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenophine substitution. Lejeune C, Simmat-Durand L, Gourarier L, Aubisson S, Groupe d'Etudes Grossesse et Addictions (GEGA). Drug Alcohol Depend; 2006 May 20; 82(3):250-7. PubMed ID: 16257138 [Abstract] [Full Text] [Related]
36. Pregnancy outcome in women who use opiates. Fajemirokun-Odudeyi O, Sinha C, Tutty S, Pairaudeau P, Armstrong D, Phillips T, Lindow SW. Eur J Obstet Gynecol Reprod Biol; 2006 Jun 01; 126(2):170-5. PubMed ID: 16202501 [Abstract] [Full Text] [Related]